Levothyroxine Therapy in Gastric Malabsorptive Disorders

Area of Science:

• Endocrinology
• Gastroenterology
• Pharmacokinetics

Background:

• Oral levothyroxine sodium absorption primarily occurs in the jejunum and ileum.
• Gastric factors are critical for the dissolution and release of levothyroxine from pharmaceutical preparations.
• Impaired gastric function can affect levothyroxine bioavailability.

Purpose of the Study:

• To review the pathophysiological mechanisms influencing oral levothyroxine absorption.
• To highlight the role of gastric conditions in levothyroxine bioavailability.
• To compare absorption of different levothyroxine formulations (tablet, softgel, liquid) in patients with gastric disorders.

Main Methods:

• Literature review of studies on levothyroxine absorption and gastric physiology.
• Analysis of factors affecting drug dissolution and gastric emptying.
• Examination of clinical evidence linking gastric disorders to levothyroxine requirements.

Main Results:

• Gastric pH, volume, viscosity, and emptying time are key limiting factors for levothyroxine absorption.
• Conditions like H. pylori infection, atrophic gastritis, and gastroparesis increase levothyroxine dosage needs.
• Alternative formulations (softgel, liquid) may offer different absorption profiles in compromised gastric environments.

Conclusions:

• The stomach is essential for preparing oral levothyroxine for intestinal absorption.
• Understanding gastric pathophysiology is vital for optimizing levothyroxine therapy.
• Further research into formulation-specific absorption in gastric disorders is warranted.